SKEZI
Paris, France
NCT Number: NCT07475338
This study is a randomized controlled trial, nested in the SKETHIS e-cohort, aiming to evaluate whether adding a modest, narrative-driven, strorytelling introduction to a Patient-Reported Outcome questionnaire increases completion without compromising data quality.
This trial is led by SKEZI, a DeepTech start-up which markets a data collection solution and carries out the InnoPRO program, aimed at generating new knowledge in the field of e-cohorts.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Paris, France
SKETHIS is a national e-cohort that serves as an observatory of health-related quality of life in France. Launched in September 2023 by SKEZI, the cohort is built as a secure health-data warehouse hosted on the SKEZIA data-collection solution. While its primary aim is to monitor health-related quality of life, its trajectories and determinants, SKETHIS is also the opportunity for SKEZI to carry out its InnoPRO program, an initiative dedicated to generate new knowledge in the field of e-cohorts.
Gamification, i.e. the integration of game-design elements, such as points, levels, or badges into non-game contexts, has been shown to increase usage, prolong retention and improve adherence to e-health services. Storytelling is a specific gamification tool that employs narrative techniques (voices, story characters, suspense, etc.) to structure a coherent, accessible and engaging participants' experience.
Improving and maintaining participant engagement is a major challenge for large-scale e-cohorts. Although gamification and storytelling have been empirically used to boost participation, the effect of storytelling on self-administered patient reported outcome questionnaires has not been evaluated in a rigorously designed randomized clinical trial.
Purpose of the study To determine whether adding a modest, narrative-driven storytelling introduction to a Patient-Reported Outcome questionnaire increases questionnaire completion without compromising data quality.
How the study will be done
This study is a parallel-group randomized controlled trial nested within SKETHIS. All eligible SKETHIS participants (i.e. participants who have completed the first questionnaire and socio-demographic questionnaire) will be randomly assigned to one of two groups:
Questions the study will answer
Hypothesis Investigators hypothesized that the integration of storytelling in self-reported Patient-Reported Outcome questionnaire will increase completion rates and participants' satisfaction, without negatively impacting data quality.
Why this matters Finding ways to increase engagement in SKETHIS, and other online cohorts, will help improving the quantity and quality of the data that can be used for future health research. The results will be shared in a peer reviewed scientific article and could guide the design of future e cohort studies worldwide.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the context of the SKETHIS e-cohort, participants receive an email inviting them to complete a new online questionnaire regarding their physical activity. Participants are unaware that the experiment is being conducted or that the questionnaire uses storytelling.
Time frame: 30 days after sending the questionnaire
Proportion of participants who complete the Patient-Reported Outcome questionnaire within 30 days after the questionnaire is first sent, calculated as number of participants who fully completed the questionnaire divided by total number of participants included in the study (or arm)
Time frame: 30 days after sending the questionnaire
Number of participants who answered additional non-mandatory questions divided by number of participants who validated the questionnaire
Time frame: 30 days after sending the questionnaire
Number of answered questions divided by time spent on the questionnaire
Time frame: 30 days after sending the questionnaire
Cronbach alpha and "floor and ceiling effects" for the Patient Reported Outcome questionnaire (Global Physical Activity Questionnaire)
Time frame: 30 days after sending the questionnaire
Score for level of physical activity calculated as per the WHO GPAQ questionnaire guideline
Time frame: 30 days after sending the questionnaire
Net promoter score: "On a scale of 0 to 5, how likely are you to recommend participation to SKETHIS to a friend or colleague?"
Time frame: 30 days after sending the questionnaire
Number of dimensions identified by grounded theory analysis for the responses to the open-ended question on satisfaction: "What would you change to make the questionnaire more enjoyable to complete?"
Time frame: 30 days after sending the questionnaire
Score for the question: "On a scale of 0 to 5, how serious do you take this scientific questionnaire?"
Time frame: 30 days after sending the questionnaire
Number of non completed questionnaires divided by number of started questionnaires
Contact information is provided by the study sponsor or research team.
SKEZI
Industry
PEGASYS (Projet d'Expérimentation Sur la Gamification et Analyse du StorYtelling Sur SKEZIA): Randomized Controlled Trial Assessing the Effect of Storytelling on Questionnaire Completion and Data Quality Within the E-Cohort SKETHIS
Acronym: PEGASYS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07492056
Disease, General Population (no Specific Condition or Disease)
View Trial DetailsNCT07147608
Behavior, Disease
Angers, France
View Trial DetailsNCT07473466
Disease, General Population (no Specific Condition or Disease)
Paris, France
View Trial DetailsNCT07212400
Disease, General Population (no Specific Condition or Disease)
Jouy-en-Josas, France
View Trial Details